A private investment group.

I

About

EP Capital Limited is a Hong Kong private investment holding company. The group deploys long-term, patient capital across real assets, healthcare, technology and digital finance, with interests spanning Asia, Europe and the Middle East.

Ownership is active and considered. The group combines disciplined capital allocation with operational involvement, building and holding businesses intended to last.

  • Real Estate
  • Pharmaceuticals
  • Medical Cannabis
  • Artificial Intelligence
  • Digital Assets
  • Intellectual Property

II

A Note from the Chairman

EP Capital was founded on a simple conviction: that the most enduring value is created patiently, by owners who understand their businesses and remain committed to them over time.

We invest across sectors and borders, but our approach does not change. We look for quality, we work closely with the people who build and run our businesses, and we hold ourselves to standards that will still matter in twenty years. Technology is reshaping every industry we touch, and we embrace it with curiosity and discipline in equal measure.

Above all, we believe that success carries responsibility, to our partners, to the communities around our operations and to the next generation.

E. PiresChairman, EP Capital Limited

A tower rising into mist

IIIApproach

EP Capital takes a long view.

Capital is committed patiently, with an emphasis on quality of asset, integrity of operations and the durability of each holding over time.

The group works closely with management and operating partners, remaining engaged in strategy, governance and execution. Decisions are measured, jurisdictions are treated with care, and each interest is expected to meet a high standard of stewardship.

IV

Holdings

Modern architectural facade

EP Capital holds a residential and commercial property portfolio across the United Kingdom, Europe, the United Arab Emirates, Japan, Malaysia and Thailand. The group concentrates on income-producing assets and on the careful, long-term management of buildings and sites in established and growing markets.

Holdings are approached as a diversified, multi-jurisdictional portfolio rather than as isolated transactions. Attention is given to occupancy, lease quality, capital expenditure and the preservation of value through changing market cycles. The group works alongside leading developers, agents and asset managers in each market, drawing on local knowledge while retaining central oversight of strategy and capital.

The emphasis is on resilient locations, considered acquisition and active asset management, with a preference for holdings that can be owned and improved over an extended horizon.

  • Residential and commercial ownership across a diversified geographic footprint
  • Active asset management, lease administration and facilities oversight
  • Collaboration with leading developers, agents and asset managers in each market
  • Capital planning, refurbishment and selective repositioning of standing assets
  • Cross-border ownership structures and jurisdiction-aware governance
  • Long-duration stewardship of income-producing real estate

Laboratory microscope

EP Capital maintains pharmaceutical operations in Thailand, with a focus on quality-led manufacturing, regulatory compliance and the reliable supply of healthcare products within the region.

The business is organised around disciplined production standards, robust quality systems and close attention to the regulatory frameworks that govern medicines and related healthcare goods. Formulation, manufacturing, quality assurance and distribution are treated as a single, accountable chain, with an emphasis on consistency, traceability and patient safety.

Through its Thai operations, the group supports access to healthcare while building a platform suited to regional market requirements and to the exacting standards of a regulated industry.

  • Pharmaceutical operations and manufacturing support in Thailand
  • Quality management, batch integrity and regulatory compliance
  • Supply-chain oversight, storage and responsible distribution
  • Regulatory affairs and engagement with applicable healthcare authorities
  • Market access and regional healthcare supply
  • Operational discipline across production, quality assurance and release

Indoor medical cannabis cultivation room

EP Capital is engaged in medical cannabis cultivation in Asia, applying advanced horticultural practice and agricultural technology to the production of consistent, compliant, pharmaceutical-grade output. Cultivation is designed around controlled-environment agriculture, with climate, irrigation, nutrition and lighting managed as an integrated system.

The group has invested in more than twelve medical cultivation facilities across Thailand. Its flagship, a 6,000 square metre facility, integrates fully automated environmental and cultivation control systems from TrolMaster and Agrowtek (Canada). In northern Thailand, the group also operates a light-deprivation greenhouse in Chiang Rai, combining natural sunlight with precise photoperiod control.

Artificial intelligence and automation are used to run farms autonomously, reducing reliance on manual intervention and improving the repeatability of each growing cycle. Internet-of-things sensor networks, environmental telemetry and data-driven cultivation inform crop steering, resource use and quality control from canopy to post-harvest.

The group develops pathways that connect Asian production with regulated international markets, including the European Union, Israel and Australia, with attention to the documentation, quality standards and chain-of-custody requirements those jurisdictions demand.

  • Investment in more than twelve medical cultivation facilities in Thailand, led by a 6,000 sq m flagship
  • Medical cannabis cultivation within controlled-environment agricultural facilities
  • Light-deprivation greenhouse cultivation in Chiang Rai
  • AI-driven automation and autonomous farm operations
  • IoT monitoring, environmental telemetry and data-driven crop steering
  • Fertigation, climate and lighting control for consistent, repeatable harvests
  • GACP, GMP and GMP PIC/S certified cultivation and production
  • ISO 9001 quality management and ISO/IEC 17025 accredited laboratory testing
  • Quality, traceability and post-harvest discipline oriented to pharmaceutical standards
  • Market pathways toward the European Union, Israel and Australia
View the cultivation estate

Abstract light and data

EP Capital invests in artificial intelligence as a core technological interest, supporting the development and application of intelligent systems across its own holdings and in the wider technology landscape.

The group's focus is on applied machine learning, automation and the practical deployment of models that improve decision-making, operations and product capability. Interest extends across data infrastructure, model development, inference and the integration of AI into day-to-day business processes, rather than research for its own sake.

Artificial intelligence is treated as both a standalone area of investment and a capability that strengthens the group's activities in agriculture, healthcare, finance and operations.

  • Investment in applied artificial intelligence and emerging technology
  • Machine learning, model development and intelligent automation
  • Data infrastructure, training pipelines and deployment architecture
  • Applied AI across operations, products and decision support
  • Evaluation of scalable platforms and enabling tools
  • Cross-sector adoption of AI within the group's own holdings

Circuit board detail

EP Capital introduces AI agents into businesses, providing a continuum of support that ranges from targeted assistance in discrete workflows through to the full operational management of processes and functions.

Engagements are designed around the realities of each organisation: existing systems, operating models and the degree of autonomy that is appropriate. The group assists with process mapping, agent design, systems integration and ongoing oversight, so that automation is introduced with control, accountability and a clear human-in-the-loop where it is required.

The aim is not novelty for its own sake, but durable improvement in efficiency, consistency and scale, with AI embedded into the way a business actually runs.

  • Introduction of AI agents for partial support or full operational management
  • Workflow automation, orchestration and process redesign
  • Integration with existing systems of record and operating tools
  • Human-in-the-loop design, governance and ongoing performance oversight
  • Change management and practical adoption within operating teams
  • Intelligent scaling of knowledge work and routine operations

Server room aisle

EP Capital is active across the digital asset and fintech landscape, spanning cryptocurrency mining, decentralised finance, digital lending and the infrastructure that supports modern financial services.

The group takes a long-term view of blockchain technology and of the tokenisation of assets, participating in the development of digital financial rails rather than in short-term market movements. Activity includes mining operations, DeFi lending, and engagement with the custody, liquidity and settlement arrangements on which a mature digital-asset market depends.

Fintech is treated as complementary to this work: payments, credit and financial infrastructure that extend the reach and usefulness of both traditional and digital finance.

  • Cryptocurrency mining and digital-asset computational infrastructure
  • Decentralised finance (DeFi) lending and on-chain credit participation
  • Digital lending and fintech infrastructure
  • Blockchain technology, asset tokenisation and digital market rails
  • Custody arrangements, liquidity access and settlement discipline
  • A long-term approach to the evolution of global financial infrastructure

Hong Kong skyline at night

EP Capital owns businesses and subsidiaries across a range of additional sectors, including digital entertainment. These interests sit alongside the group's principal activities and reflect a preference for scalable, technology-enabled models.

Holdings are selected and managed with the same long-term orientation applied elsewhere in the portfolio: considered ownership, operational engagement and a close working relationship with management. The group looks for businesses with durable demand, sound operating discipline and the capacity to develop over time.

Digital entertainment forms part of this diversified activity, approached as a contemporary media and content interest rather than as a short-cycle trade.

  • Ownership of operating businesses and subsidiaries across multiple sectors
  • Digital entertainment as a distinct area of diversified interest
  • Technology-enabled models with scalable operating characteristics
  • Active ownership and engagement with management teams
  • Support for operational improvement, governance and long-term development
  • A diversified complement to the group's core sector holdings

Spiral stair beneath a skylight

EP Capital holds a portfolio of licences and intellectual property across its operating sectors. These rights underpin the group's businesses and are treated as long-term assets in their own right, not merely as formalities of operation.

The portfolio includes proprietary software intellectual property, together with intellectual property in artificial intelligence and in medical cannabis cultivation technology. Software assets are developed and maintained as a disciplined body of work, supporting automation, operations and product capability across the group.

Taken together, the group's licences and IP provide a foundation for scalable, defensible activity in regulated and technology-intensive fields, and for the continued development of its operating platforms.

  • A portfolio of operating licences across relevant jurisdictions and sectors
  • Proprietary software intellectual property
  • Intellectual property in artificial intelligence
  • Intellectual property in medical cannabis cultivation technology
  • Internal development practice supporting the group's software and technology assets
  • Long-term stewardship of IP as a core group asset

IVHoldings

Medical Cannabis & Agri-Tech

The group has invested in more than twelve medical cultivation facilities across Thailand. Its flagship, a 6,000 square metre facility, integrates fully automated environmental and cultivation control systems from TrolMaster and Agrowtek (Canada).

V

Principles

  1. I

    Long-term orientation.

    Capital is committed with patience, measured in years and decades rather than quarters.

  2. II

    Active stewardship.

    The group stays close to its holdings, engaged in strategy, governance and execution.

  3. III

    Integrity and discretion.

    Relationships are conducted privately, with care and with respect for every party involved.

  4. IV

    Innovation with discipline.

    New technology is embraced where it creates lasting value, and approached with rigour.

  5. V

    Responsibility.

    Each holding is expected to contribute positively to the people and communities it touches.

VI

Governance & Responsible Investment

Across its operations, the group holds GACP, GMP, GMP PIC/S, ISO 9001 and ISO/IEC 17025 certifications, reflecting internationally recognised standards in cultivation, manufacturing, quality management and laboratory testing.

  • GACPGood Agricultural & Collection Practice
  • GMPGood Manufacturing Practice
  • GMP PIC/SPharmaceutical Inspection Co-operation Scheme
  • ISO 9001Quality Management
  • ISO/IEC 17025Laboratory Testing

EP Capital operates with a strong emphasis on governance, compliance and risk management across every jurisdiction in which it is active. Holdings are structured with care, overseen centrally, and held to consistent standards of reporting and accountability.

Environmental, social and governance considerations form part of the group's thinking from the outset. The group favours efficient, sustainable operations, responsible use of resources and businesses that treat their people, partners and communities well.

Laboratory sample preparation

VII

Global Perspective

Headquartered in Hong Kong, EP Capital looks across Asia, Europe and the Middle East. The group combines an international outlook with a close understanding of local markets, regulation and culture, allowing it to move between jurisdictions with confidence and care.

United KingdomEuropeUAEThailandMalaysiaHong KongJapan
Map of markets: United Kingdom, Europe, United Arab Emirates, Hong Kong, Japan, Malaysia and Thailand.
  • United Kingdom
  • Europe
  • United Arab Emirates
  • Hong Kong
  • Japan
  • Malaysia
  • Thailand
Dubai skyline
Hong Kong skyline at night
Tokyo at night
Light-deprivation greenhouse in Chiang Rai

VIII

Sustainability

Efficiency and sustainability are built into the way the group operates.

Automated, controlled-environment cultivation reduces water, energy and nutrient waste; data-led management improves the performance of buildings and facilities; and the group favours technologies that do more with less.

IX

Philanthropy

EP Capital believes that long-term ownership carries long-term responsibility. The group's giving is focused on children in Thailand who are growing up without family support or the basic means that most take for granted.

Support is given every week, not as occasional gestures, and the group works closely with a small number of children's homes and community organisations that it supports directly. The aim is steady, practical care: food, shelter, education and the stability to grow up well.

In time, EP Capital intends to establish its own foundation dedicated to this work.

X

Partnerships

EP Capital is always seeking new investments and strategic partnerships. The group welcomes introductions to businesses, founders and co-investors whose ambitions and standards sit comfortably with its long-term approach.

Relationships are formed patiently and with care. The group looks for alignment in outlook, quality of operation and the potential to build something durable together.

Make an introduction

Partners

  • Agrowtek
  • TrolMaster
  • Prakan MedicalThailand
  • Athena Nutrients
  • SOMAƍ Pharmaceuticals
  • GitHub

XIPeople

EP Capital is built on the strength of its people.

With interests spanning many businesses and sectors, the group can often find the right place for exceptional individuals, whatever their background.

We welcome people who share our long-term outlook, our curiosity about technology and our commitment to doing things well. Expressions of interest are welcome through the form below.

Express interest
A figure crossing a modern plaza

XII

Contact

Enquiries and introductions may be made through the form below.

EP Capital Limited
Hong Kong

Submissions are treated in confidence.